First Human Trial to Slash Bad Cholesterol by 50% With One Injection of CRISPR Gene-Editing Therapy
Mundo Positivo

First Human Trial to Slash Bad Cholesterol by 50% With One Injection of CRISPR Gene-Editing Therapy

21 de noviembre de 2026

A one-time infusion of CRISPR gene editing therapy slashed dangerous cholesterol by 52%, with the patients still experiencing the benefit 12 months after initial treatment, and without side effects. The Cleveland Clinic in Ohio reported that their Phase 1 human trial showed a one-time infusion of a gene-editing therapy using CRISPR-Cas9 was effective and safe […] The post First Human Trial to Slash Bad Cholesterol by 50% With One Injection of CRISPR Gene-Editing Therapy appeared first on Good Ne

A one-time infusion of CRISPR gene editing therapy slashed dangerous cholesterol by 52%, with the patients still experiencing the benefit 12 months after initial treatment, and without side effects. The Cleveland Clinic in Ohio reported that their Phase 1 human trial showed a one-time infusion of a gene-editing therapy using CRISPR-Cas9 was effective and safe […] The post First Human Trial to Slash Bad Cholesterol by 50% With One Injection of CRISPR Gene-Editing Therapy appeared first on Good News Network .

Vía: Good News Network

Comentarios (0)

Aún no hay comentarios. ¡Sé el primero en opinar!